News & Events zu Origin Agritech Ltd (SEED)SEEDOrigin Agritech Ltd

Origin Agritech's Three Corn Varieties Pass Preliminary Review

Origin Agritech announced that three of its corn varieties, Aoxiangyu 819, Aoyu 966 and Aoyu 288, have passed the preliminary review of the 13th Session of the Fifth National Crop Variety Approval Committee of China. The three varieties are bred for the Huang-Huai-Hai Summer Corn Region, one of China's major corn-producing areas, and delivered yield gains of 6.0% to 8.6% over control varieties in two-year national regional trials. Preliminary review is followed by a 30-day public notice period, which runs from October 22 through November 22. "The preliminary review of these three varieties is an important milestone for Origin's breeding and commercialization pipeline. Their consistent yield performance across regional and production trials demonstrates the strength of our breeding capabilities and provides additional products for our expansion in the Huang-Huai-Hai region," said Weibin Yan, CEO.

Origin Agritech Sells 70.52% Stake in Xinjiang Seed for RMB 108M

Origin Agritech announced that its indirect subsidiary, Beijing Origin Agriculture, has entered into an equity transfer agreement to sell its 70.5184% equity interest in Xinjiang Originbo Seed, the Company's principal corn seed production and processing base, to Hunan Xindaxin for RMB 108M. Beijing Origin has also signed a five-year lease for all the buildings, machinery, equipment, and other assets comprising the Base, running from October 1, 2026, to September 30, 2031.

Origin Agritech Unveils Southwest R&D Center in Guiyang

Origin Agritech unveiled its Southwest R&D Center in Kaiyang County, Guiyang City, Guizhou Province, on the second anniversary of the company's relaunch. The center is anchored by two entities established earlier this year: Guizhou Origin Biotechnology, a wholly owned subsidiary, and Guiyang Agricultural Investment Origin Modern Seed Industry, a state-controlled company in which Origin holds a 25% equity interest. Together, they span research, propagation, promotion, and commercialization across the Southwest region. The approximately 8,000-square-meter complex houses a 4,000-square-meter experimental zone, a 600-square-meter molecular testing platform, a 2,000-square-meter tissue culture platform, and four intelligent glass greenhouses totaling more than 15,000 square meters, supported by roughly 160 mu of standardized field trial land. This facility is part of Guizhou Origin, a research company wholly owned by Origin. It stands as one of the company's four research stations and is currently the largest in terms of floor space. With its infrastructure, it is poised to become the most significant biotech research center in China. Notably, Guizhou Origin supports Origin's biotech operations nationwide, whereas the joint venture is dedicated to serving businesses in southwest China.